SCHEMBL4352899

SCHEMBL4352899

O=C(Nc1cccc(Cl)c1O)N(Cc1ccccc1)C1=COCO1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.41
ERBB2 P04626 4/20 0.41
TRPV1 Q8NER1 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
MAPT P10636 3/20 0.36
UBE2M P61081 2/20 0.36
DCUN1D1 Q96GG9 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ABCC1 P33527 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355478 0.88 EGFR (0.43) EGFRERBB2TRPV1SMN1; SMN2ALOX15
SCHEMBL4341341 0.87 RAB9A (0.36) EGFRERBB2TRPV1SMN1; SMN2ALOX15
SCHEMBL4347969 0.84 EGFR (0.43) EGFRERBB2MAPTUBE2MDCUN1D1
SCHEMBL4342089 0.83 ALDH1A1 (0.34) EGFRERBB2SMN1; SMN2ALOX15TSHR
SCHEMBL4345516 0.82 ALOX15 (0.48) SMN1; SMN2ALOX15TSHRHTTMAPT
SCHEMBL4355633 0.82 PDK1 (0.43) TRPV1UBE2MDCUN1D1ABCC1
SCHEMBL6565568 0.80 GAA (0.45) HTTUBE2MDCUN1D1ALDH1A1MEN1
SCHEMBL4345577 0.80 HDAC3 (0.36) EGFRERBB2TRPV1SMN1; SMN2ALOX15
SCHEMBL4354386 0.80 CCR2 (0.41) EGFRERBB2MAPTUBE2MDCUN1D1
SCHEMBL4351435 0.79 UBE2M (0.35) EGFRERBB2SMN1; SMN2ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 EGFR 1661/4885ERBB2 1297/4885TRPV1 2328/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 EGFR 1635/4885ERBB2 1020/4885TRPV1 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.